References
- Benz MS, Scott IU, Flynn HW, Jr, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004; 137: 38–42
- Binder, MI, Chua, J, Kaiser, PK, Procop, GW, Isada, CM. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine, (Baltimore), 2003; 82: 97–105.
- Feman SS, Nichols JC, Chung SM, Theobald TA. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc 2002; 100: 67–70
- Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000; 13: 662–685
- Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qiu H. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina 2001; 21: 203–209
- Kim RW, Juzych MS, Eliott D. Ocular manifestations of injection drug use. Infect Dis Clin North Am 2002; 16: 607–622
- Gupta A, Gupta V, Dogra MR, et al. Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid. Retina 2000; 20: 262–268
- Strahilevitz J, Rahav G, Schroers HJ, et al. An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. Clin Infect Dis 2005; 40: 781–786
- Ciobotaro, P, Strahilewitz, J, Sigma-Igra, Y, , et al. An outbreak of Phialemonium curvatum (P.c) infections in patients with erectile dysfunction. 43rd Interscience Conference on Antimicroial. Agents and Chemotherapy, Chicago, 14–17, September, 2003: abstr. K-1431.
- Rinaldi MG. Use of potato flakes agar in clinical mycology. J Clin Microbiol 1982; 15: 1159–1160
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS document M38-A. National Committee for Clinical Laboratory Standards: Wayne, PA. 2002.
- Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother 2001; 45: 327–330
- Kurtz MB, Heath IB, Marrinan J, et al. Morphological effect of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother 1994; 38: 1480–1489
- White TJ, Bruns T, Lee SJT. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. A Guide to Methods and Applications, MA Innis, DH Gelfand, JJ Sninsky, TJ White. Academic Press, San Diego 1990; 315–322
- Guarro J, Nucci M, Akiti T, et al. Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol 1999; 37: 2493–2497
- Gams W, McGinnis MR. Phialemonium, a new anamorph genus intermediate between Phialophora and Acremonium. Mycologia 1983; 75: 977–987
- King D, Pasarell L, Dixon DM, McGinnis MR, Merz WG. A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol 1993; 31: 1804–1810
- Proia LA, Hayden MK, Kammeyer PL, et al. Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis 2004; 39: 373–379
- Gavin PJ, Sutton DA, Katz BZ. Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol 2002; 40: 2207–2212
- Heins-Vaccari EM, Machado CM, Saboya RS, et al. Phialemonium curvatum infection after bone marrow transplantation. Rev Inst Med Trop Sao Paulo 2001; 43: 163–166
- Magnon KC, Jalbert M, Padhye AA. Osteolytic phaeohyphomycosis caused by Phialemonium obovatum. Arch Pathol Lab Med 1993; 117: 841–843
- McGinnis MR, Gams W, Goodwin MN, Jr. Phialemonium obovatum infection in a burned child. J Med Vet Mycol 1986; 24: 51–55
- Schonheyder HC, Jensen HE, Gams W, et al. Late bioprosthetic valve endocarditis caused by Phialemonium aff. curvatum and Streptococcus sanguis: a case report. J Med Vet Mycol 1996; 34: 209–214
- Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol 1990; 143: 1138–1141
- Leungwattanakij S, Flynn V, Jr, Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001; 28: 343–354
- Parfitt VJ, Wong R, Dobbie A, Hartog M, Gingell JC. Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes. Diabet Med 1992; 9: 947–949
- Schwarzer JU, Hofmann R. Purulent corporeal cavernositis secondary to papaverine-induced priapism. J Urol 1991; 146: 845–846
- Biswas J. Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid. Retina 2001; 21: 93–94
- Anonymous. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy – United States, July–November 2002. Morb Mortal Wkly Rep 2002; 51: 1109–1112.
- Shankland GS, Richardson MD. Epidemiology of an outbreak of Candida endophthalmitis in heroin addicts: identification of possible source of infection by biotyping. J Med Vet Mycol 1988; 26: 199–202